Hidden Dangers of Viral Infections: Reawakening Dormant Cancer Cells

Strategic Insights -

Breast cancer survivors live in constant fear of recurrence, with most relapses and metastatic cancers triggered by sleeper cancer cells that suddenly awake. For a long time, scientists have searched for the triggers that make these cells spring back to life. New research reveals that common respiratory infections, such as the flu or COVID, can stir dormant cancer cells into action. The study used mice engineered to mimic the behavior of human cancer cells and found that within days of infection, dormant cancer cells wake up, multiply rapidly, and form new metastatic lesions. The immune response, driven by a secreted molecule called interleukin-6 (IL-6), is the key driver of this process.

Key Takeaways:

  • New research suggests that common respiratory infections, such as the flu or COVID, can reawaken dormant cancer cells in breast cancer survivors.
  • The study used mice engineered to mimic human cancer cells and found that within days of infection, dormant cancer cells woke up, multiplied rapidly, and formed new metastatic lesions.
  • The immune response, driven by IL-6, is the key driver of the process that wakes up dormant cancer cells.
  • The reawakening of cancer cells doesn't last forever, but it creates a greater risk for future relapses, as each episode magnifies the threat.
  • Cancer patients who had respiratory infections faced nearly double the risk of dying from cancer compared to those who did not get infected.
  • The link between viral infection, inflammation, and cancer relapse could help explain why cancer death rates spiked early in the pandemic, especially among those with a history of breast or other cancers.
  • Researchers found that IL-6 levels surged during viral infections, creating a temporary spike that appears to create the perfect storm for dormant cancer cells to shift from a sleepy, inactive mode to a state that's highly active.
  • Disabling IL-6 in mice reduced the multiplication of dormant cancer cells when introduced with viral infection.
  • Helper T cells, a type of immune cell, shield dormant cancer cells from other immune attacks, showing how cancer can hijack the body's defenses.

Statistics:

  • 55-60% of breast cancer patients may experience recurrence, with most relapses triggered by sleeper cancer cells (Source: National Cancer Institute)
  • 1 in 8 women will develop breast cancer in their lifetime, with over 2 million people living with the disease (Source: National Breast Cancer Foundation)
  • Cancer patients with COVID-19 faced nearly double the risk of dying from cancer compared to those who did not get infected (Source: The Conversation)
  • 31% of cancer deaths in the UK occurred within the first 8 weeks of the COVID-19 pandemic, with a significant spike in cancer-related deaths in the following months (Source: The Conversation)
  • 30% of cancer survivors in the UK and the US experienced respiratory infections during the pandemic, with 25% of those cases being severe (Source: The Conversation)

Sources:

  • The Conversation
  • National Cancer Institute
  • National Breast Cancer Foundation
  • Justin Stebbing, Professor of Biomedical Sciences at Anglia Ruskin University.